Blackrock Investing Cash Flow decreased by 32.1% to -$280.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 91.6%, from -$3.34B to -$280.00M. Over 2 years (FY 2022 to FY 2025), Investing Cash Flow shows a downward trend with a 98.9% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$282.50M | -$282.50M | -$282.50M | -$282.50M | -$186.00M | -$22.00M | $163.00M | -$74.00M | -$3.07B | -$3.34B | $0.00 | -$923.00M | -$212.00M | -$280.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +34.2% | +88.2% | +840.9% | -145.4% | <-999% | -8.6% | +100.0% | — | +77.0% | -32.1% |
| YoY Change | — | — | — | — | +34.2% | — | — | — | <-999% | <-999% | -100.0% | <-999% | +93.1% | +91.6% |